Tower Research Capital LLC (TRC) - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 190 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$261,000
+278.3%
27,672
+205.7%
0.00%0.0%
Q2 2020$69,000
-4.2%
9,053
+52.3%
0.00%
-50.0%
Q4 2019$72,000
-45.0%
5,945
-47.7%
0.01%
-33.3%
Q3 2019$131,000
-34.5%
11,377
-43.2%
0.01%
-30.8%
Q2 2019$200,000
+15.6%
20,021
+130.5%
0.01%0.0%
Q3 2018$173,000
+8550.0%
8,685
+8093.4%
0.01%
Q2 2017$2,000
-95.7%
106
-95.0%
0.00%
-100.0%
Q1 2017$47,000
-54.8%
2,100
-29.9%
0.01%
-54.5%
Q4 2016$104,000
+126.1%
2,997
+60.4%
0.01%
+120.0%
Q3 2016$46,000
+142.1%
1,868
+292.4%
0.01%
+150.0%
Q3 2015$19,000
-75.0%
476
-57.0%
0.00%
-71.4%
Q2 2015$76,000
-70.5%
1,106
-76.5%
0.01%
-78.1%
Q1 2015$258,000
+15.7%
4,714
-10.0%
0.03%
+45.5%
Q4 2014$223,000
+125.3%
5,240
+68.4%
0.02%
+100.0%
Q3 2014$99,000
+661.5%
3,111
+364.3%
0.01%
+450.0%
Q1 2014$13,000
-71.7%
670
-65.0%
0.00%
-75.0%
Q4 2013$46,000
+360.0%
1,914
+330.1%
0.01%
+700.0%
Q3 2013$10,000
+11.1%
445
+5.5%
0.00%0.0%
Q2 2013$9,0004220.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders